ImmunoGen's (IMGN) CEO Mark Enyedy on Q2 2017 Results - Earnings Call Transcript

2/21/17

ImmunoGen, Inc. (NASDAQ:IMGN)

Q2 2017 Earnings Conference Call

February 17, 2017, 08:00 AM ET

Executives

Sarah Kiely - Manager, IR & Corporate Communications

Mark Enyedy - President & CEO

Dave Johnston - CFO

Anna Berkenblit - Chief Medical Officer

Richard Gregory - Executive Vice President and Chief Scientific Officer

Analysts

Biren Amin - Jefferies

John Newman - Canaccord

Cyrus Amoozegar - Morgan Stanley

Jessica Fye - JPMorgan

Boris Peaker - Cowen

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.